Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The veteran's small cell lung cancer has been in remission since 2004, and the residuals do not result in FEV-1 of 56 to 70 percent predicted, FEV-1/FVC of 56 to 70 percent, or DLCO (SB) of 56 to 65 percent predicted. The reduction from 100% was proper and a 10% rating is appropriate.

The deciding factor: The veteran's small cell lung cancer has been in remission since 2004, with no conclusive evidence of a recurrent active pathology.

Claimed conditions
Small Cell Lung Cancer
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
10%
Decision date
January 15, 2008
Citation
0801561

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 0801561.

What this means for you

A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.